Partner Christopher Armstrong was quoted by The Wall Street Journal after senators pressed drug company executives during a three and a half hour hearing on drug prices. The executives expressed a lot of support over removing the burden of high drug prices, but stated that some companies negotiate for rebates of their products, but do not pass on those savings to patients. Mr. Armstrong goes on to discuss that with the 2020 campaign approaching, healthcare is poised to be a central issue for voters.
"It certainly seems like it’s a new day for drug companies in Congress. How the industry handles these hearings and investigations is likely to have enormous effect on their businesses moving forward,” said Mr. Armstrong.
READ: Senators Press Drug-Company Executives Over Prices (Subscription Required)
Please note that email communications to the firm through this website do not create an attorney-client relationship between you and the firm. Do not send any privileged or confidential information to the firm through this website. Click "accept" below to confirm that you have read and understand this notice.